
Joseph Papa continues to remodel the plagued Valeant Pharmaceuticals, as a senior management shake-up has seen several new arrivals and …

Valeant (NYSE: VRX) has announced the establishment of a new patient access and pricing committee that will be responsible for …

Valeant Pharmaceuticals has announced that Joseph C. Papa will succeed Michael Pearson as chairman and chief executive officer of the …

